ONE-WAYOngoing theme · still written in the latest filings
Growth through the early development of innovative medicines
A theme focused on advancing the early development of large-scale, innovative pharmaceuticals following the existing COPD treatment through upfront investment, in-house clinical trials and partnerships, thereby increasing product value and driving corporate growth.
Companies2How many companies write about this.
Threads2One company can carry more than one thread here.
PeriodFY2016 →Still being written about.
Directionhelps2 helps · 0 hurts · 0 flat